HBAN vs JANX · P/E 13, rev $1.56B vs rev $10.3M
Huntington Bancshares Incorporated (HBAN) versus Janux Therapeutics Inc (JANX) — a side-by-side from cached financials, not a winner call.
Huntington Bancshares Incorporated (HBAN) is a banks - regional company listed on US.
Janux Therapeutics Inc (JANX) is a biotechnology company listed on US.
Latest reported HBAN revenue for 2025-12-31 was $1.56B. Net income was $2.21B. Revenue was up 6.4% from 2024-12-31 to 2025-12-31. HBAN currently screens at market cap $25.55B and trailing P/E 13.5.
Latest reported JANX revenue for 2026-06-30 was $10.3M. Net income was -$22.0M. JANX currently screens at market cap $1.49B.
HBAN currently screens at market cap $25.55B and trailing P/E 13.5. JANX currently screens at market cap $1.49B.
Not investment advice. Open the HBAN and JANX stock pages for the full models.
Not investment advice.